Identification and Evaluation of Drug-Related Problems in Elderly Hypertensive Patients

Nadia Alrawaiq; Siraj Iseidiyah; Bassam Khattab

doi:10.69667/lmj.2517310

Authors

Nadia Alrawaiq General Department, Faculty of Pharmacy, Sebha University, Sebha, Libya https://orcid.org/0000-0001-8819-8733
Siraj Iseidiyah General Department, Faculty of Pharmacy, Sebha University, Sebha, Libya https://orcid.org/0009-0009-5428-6634
Bassam Khattab General Department, Faculty of Pharmacy, Sebha University, Sebha, Libya https://orcid.org/0000-0001-7525-7087

DOI:

https://doi.org/10.69667/lmj.2517310

Keywords:

Drug‑Related Problems, Hypertension, The Elderly, Inpatient.

Abstract

The phrase "Problems related to the drug" serves as a comprehensive term for any condition or care related to the patient, whether it is currently or potentially obstructing the best possible results for the patient. Individuals diagnosed with high blood pressure have an increased risk of experiencing drug-related problems, largely due to their regular drug intake and the existence of many concurrent health issues. Thus, there has been a significant decrease in research focused on elderly patients with high blood pressure till now. The purpose of this investigation is to evaluate drug-related problems and identify the determinants affecting these issues within this demographic. The retrospective analysis was done from January 2021 to February 2021 at a healthcare facility in Libya. The sample included patients diagnosed with chronic high blood pressure. The study identified a total of 70 persons associated with problems related to 404 drugs. Within the investigated population, 81.4% displayed a drug-related problem, with an average of 5. 7 were per capita on issues. Adverse events emerged as a leading category of drug-related problems, which represent 59.29% in total cases. The second most commonly found type of drug-related problem was indicated, which was 18.6% of all recorded issues. Monitoring problems were the third most often, including 17. 3%of the overall count. In contrast, dosage-related complications were at least as frequent, which contribute only 4.7%of all medicines related to medicines. It is important to identify the types and trends of drug-related problems in patients suffering from high blood pressure to prevent and improve management of these issues. It is necessary to apply effective strategies to reduce the incidence of complications related to treatment within this susceptible group

References

Pokharel Y, Karmacharya BM, Neupane D. Hypertension—A silent killer without global bounds: What next? : American College of Cardiology Foundation Washington DC; 2022. p. 818-20.

Soliman SS, Guseman EH, Haile ZT, Ice G. Prevalence and determinants of hypertension unawareness among Egyptian adults: The 2015 EHIS. Journal of Human Hypertension. 2020:1-8.

Tailakh A, Evangelista LS, Mentes JC, Pike NA, Phillips LR, Morisky DE. Hypertension prevalence, awareness, and control in A rab countries: A systematic review. Nursing & health sciences. 2014;16(1):126-30.

Taher YA, Sherif FM. Prevalence of associated risk factors of hypertension in Libyan patients. J Pharmacol Clin Res. 2017;4(1):1-7.

Balha A, Fadhlullah A, Abdalgwad R. The Association Between Ischemic Heart Disease and Hypertension in Libyan Adults: A Cross-Sectional Study. AlQalam Journal of Medical and Applied Sciences. 2022 Apr 16:206-9.

Alrawaiq N, Khattab B, Iseidiyah S. Evaluation of Drug Interactions in Elderly Hypertensive Patients: A Retrospective Study. AlQalam Journal of Medical and Applied Sciences. 2025:1039-42.

Endalifer BL, Kassa MT, Ejigu YW, Ambaye AS. Polypharmacy, drug–drug interactions, and potentially inappropriate medications among older adults: a cross-sectional study in Northeast Ethiopia. Frontiers in Public Health. 2025;13:1525079.

Bektay MY, Ayhan YE, Çakmak M, Mercumek B. Identification and evaluation of drug-related problems in community pharmacy in Turkey: a descriptive prevalence study. BMC Primary Care. 2025;26:248.

Kusumawardani LA, Andrajati R, Nusaibah A. Drug-related problems in hypertensive patients: A cross-sectional study from Indonesia. Journal of Research in Pharmacy Practice. 2020;9(3):140-5.

Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, et al. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Scientific reports. 2021;11(1):1-11.

Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. The Lancet. 2007;370(9582):185-91.

Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ: Canadian Medical Association Journal. 1996;154(8):1177.

Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? The American journal of geriatric pharmacotherapy. 2007;5(1):31-9.

Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circulation research. 2019;124(7):1124-40.

Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC endocrine disorders. 2013;13(1):2.

Redzuan A, Ramli A, Pheng M. Drug-related problems in hypertensive patients with multiple comorbidities. J Pharm Res. 2017;1(3):000113.

Hussein M, Lenjisa J, Woldu M, Tegegne G, Umeta G, Dins H. Assessment of drug related problems among hypertensive patients on follow up in Adama Hospital Medical College, East Ethiopia. Clinic Pharmacol Biopharmaceut. 2014;3(122):2.

Alrawaiq N, Nassr E, Matr A. Identification and Evaluation of Drug-related Problems Associated with Angiotensin Converting Enzyme Inhibitor Use. AlQalam Journal of Medical and Applied Sciences. 2025:1564-73.

Sumi H, Tominaga N, Fujita Y, Verbalis JG. Treatment of hyponatremia: comprehension and best clinical practice. Clinical and experimental nephrology. 2025;29(3):249-58.

Rao M, Sudhir U, Anil Kumar T, Saravanan S, Mahesh E, Punith K. Hospital-based descriptive study of symptomatic hyponatremia in elderly patients. J Assoc Physicians India. 2010;58:667-9.

Clayton J, Le Jeune I, Hall I. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. Journal of the Association of Physicians. 2006;99(8):505-11.

Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. New England Journal of Medicine. 1986;314(24):1529-35.

Arieff AI, Ayus JC, Fraser CL. Hyponatraemia and death or permanent brain damage in healthy children. British Medical Journal. 1992;304(6836):1218-22.

Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Annals of Internal Medicine. 1992;117(11):891-7.

Agarwal M, Lynn KL, Richards AM, Nicholls MG. Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertension. 1999;33(4):1020-4.

De Carvalho H, Richard MC, Chouihed T, Goffinet N, Le Bastard Q, Freund Y, et al. Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case–control study. Internal and Emergency Medicine. 2021:1-6.

Wenger NS, Roth CP, Shekelle P, Investigators A. Introduction to the assessing care of vulnerable elders‐3 quality indicator measurement set. Journal of the American Geriatrics Society. 2007;55:S247-S52.

Hawkins RC. Gender and age as risk factors for hypokalemia and hyperkalemia in a multiethnic Asian population. Clinica chimica acta; international journal of clinical chemistry. 2003;331(1-2):171-2.

Chen B, Counts CJ, Maresca P, Greller HA, Heller MJ. Simultaneous cases of familial hypokalemic periodic paralysis induced by illicit injection of betamethasone. The Journal of Emergency Medicine. 2025;70:92-7.

Tudorache YM, Andersen IT, Hjelholt TJ, Kristensen MT, Sheehan KJ, Pedersen AB. Association between early mobilization after hip fracture surgery and risk of long-term opioid therapy. European Geriatric Medicine. 2025:1-11.

Hussen A, Daba FB. Drug therapy problems and their predictors among hypertensive patients on follow up in Dil-Chora Referral Hospital, Dire-Dawa, Ethiopia. hypertension. 2017;5(7).

Herings R, De Boer A, Leufkens H, Porsius A, Stricker BC. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. The Lancet. 1995;345(8959):1195-8.

Morris AD, Boyle DI, McMahon AD, Pearce H, Evans JM, Newton RW, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care. 1997;20(9):1363-7.

Alrawaiq N, Nassr E, Alhussein S. Evaluation of NSAID-Drug Interactions in Elderly Patients: A Retrospective Study. Attahadi Medical Journal. 2025:197-200.